Business ❯Finance ❯Mergers and Acquisitions
Oncology Novo Holdings Acquisition Neurological Disorders Walgreens Business Sale Biotechnology Biotech Companies 23andMe Supernus Pharmaceuticals Immunology Rare Diseases Biontech-Curevac Acquisition Sanofi Torrent Pharmaceuticals
The Q3 closing will add Blueprint’s FDA-approved systemic mastocytosis therapy Ayvakit alongside late-stage candidates to Sanofi’s portfolio.